The ESHRE revised endometriosis classification (2023 #Endo) differs from the revised ASRM (rASRM) scoring in that it:
- A Correlates better with pain symptoms than the rASRM score
- B Relies purely on serum CA-125 and ultrasound without surgical data
- C Predicts fertility outcomes more accurately by including deep endometriosis morphology ✓
- D Has replaced the rASRM scoring system entirely in international guidelines
Correct answer: C. Predicts fertility outcomes more accurately by including deep endometriosis morphology
Explanation
The ESHRE 2023 #Endo classification combines surgical findings with ultrasound-based characterisation of deep infiltrating endometriosis (DIE) and ovarian endometriomas, providing better prognostic information for fertility treatment planning than the older rASRM scoring system, which correlates poorly with pain or fertility outcomes. Neither system reliably predicts pain intensity. The rASRM continues to be widely used alongside the newer ESHRE system.
Reference: Shaw's Textbook of Gynaecology, 17th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.